vs
Side-by-side financial comparison of Chemours Co (CC) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.1× Chemours Co). Chemours Co runs the higher net margin — -3.5% vs -13.6%, a 10.1% gap on every dollar of revenue. On growth, Chemours Co posted the faster year-over-year revenue change (-2.1% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $92.0M). Over the past eight quarters, Chemours Co's revenue compounded faster (-1.2% CAGR vs -3.6%).
The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
CC vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.5B |
| Net Profit | $-47.0M | $-205.0M |
| Gross Margin | 11.7% | 49.2% |
| Operating Margin | — | -9.8% |
| Net Margin | -3.5% | -13.6% |
| Revenue YoY | -2.1% | -5.3% |
| Net Profit YoY | -261.5% | -288.1% |
| EPS (diluted) | $-0.32 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.5B | $1.6B | ||
| Q2 25 | $1.6B | $1.6B | ||
| Q1 25 | $1.4B | $1.5B | ||
| Q4 24 | $1.4B | $1.6B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.6B | $1.6B | ||
| Q1 24 | $1.4B | $1.6B |
| Q4 25 | $-47.0M | $-205.0M | ||
| Q3 25 | $46.0M | $160.0M | ||
| Q2 25 | $-380.0M | $145.0M | ||
| Q1 25 | $-5.0M | $87.0M | ||
| Q4 24 | $-13.0M | $109.0M | ||
| Q3 24 | $-32.0M | $359.0M | ||
| Q2 24 | $60.0M | $195.0M | ||
| Q1 24 | $54.0M | $201.0M |
| Q4 25 | 11.7% | 49.2% | ||
| Q3 25 | 15.6% | 53.5% | ||
| Q2 25 | 17.2% | 54.8% | ||
| Q1 25 | 17.3% | 55.6% | ||
| Q4 24 | 19.4% | 56.3% | ||
| Q3 24 | 19.0% | 58.3% | ||
| Q2 24 | 19.8% | 58.4% | ||
| Q1 24 | 20.9% | 59.0% |
| Q4 25 | — | -9.8% | ||
| Q3 25 | 2.5% | 15.2% | ||
| Q2 25 | -15.4% | 14.4% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | -0.1% | 8.1% | ||
| Q3 24 | -2.1% | 13.1% | ||
| Q2 24 | 4.4% | 14.6% | ||
| Q1 24 | 5.1% | 14.5% |
| Q4 25 | -3.5% | -13.6% | ||
| Q3 25 | 3.1% | 10.0% | ||
| Q2 25 | -23.5% | 9.1% | ||
| Q1 25 | -0.4% | 5.8% | ||
| Q4 24 | -1.0% | 6.8% | ||
| Q3 24 | -2.1% | 22.7% | ||
| Q2 24 | 3.9% | 12.1% | ||
| Q1 24 | 4.0% | 12.4% |
| Q4 25 | $-0.32 | $-0.78 | ||
| Q3 25 | $0.31 | $0.61 | ||
| Q2 25 | $-2.53 | $0.56 | ||
| Q1 25 | $-0.03 | $0.33 | ||
| Q4 24 | $-0.07 | $0.42 | ||
| Q3 24 | $-0.22 | $1.38 | ||
| Q2 24 | $0.39 | $0.75 | ||
| Q1 24 | $0.36 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $670.0M | $574.0M |
| Total DebtLower is stronger | $4.1B | $8.6B |
| Stockholders' EquityBook value | $250.0M | $752.0M |
| Total Assets | $7.4B | $12.9B |
| Debt / EquityLower = less leverage | 16.40× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $670.0M | $574.0M | ||
| Q3 25 | $613.0M | $672.0M | ||
| Q2 25 | $502.0M | $599.0M | ||
| Q1 25 | $464.0M | $547.0M | ||
| Q4 24 | $713.0M | $675.0M | ||
| Q3 24 | $596.0M | $763.0M | ||
| Q2 24 | $604.0M | $704.0M | ||
| Q1 24 | $746.0M | $575.0M |
| Q4 25 | $4.1B | $8.6B | ||
| Q3 25 | $4.1B | $8.8B | ||
| Q2 25 | $4.1B | $8.9B | ||
| Q1 25 | $4.1B | $9.0B | ||
| Q4 24 | $4.1B | $8.9B | ||
| Q3 24 | $4.0B | $8.7B | ||
| Q2 24 | $4.0B | $8.7B | ||
| Q1 24 | $4.0B | $8.7B |
| Q4 25 | $250.0M | $752.0M | ||
| Q3 25 | $274.0M | $906.0M | ||
| Q2 25 | $228.0M | $733.0M | ||
| Q1 25 | $566.0M | $542.0M | ||
| Q4 24 | $571.0M | $472.0M | ||
| Q3 24 | $643.0M | $493.0M | ||
| Q2 24 | $714.0M | $144.0M | ||
| Q1 24 | $753.0M | $48.0M |
| Q4 25 | $7.4B | $12.9B | ||
| Q3 25 | $7.5B | $13.6B | ||
| Q2 25 | $7.5B | $13.5B | ||
| Q1 25 | $7.4B | $13.2B | ||
| Q4 24 | $7.5B | $13.1B | ||
| Q3 24 | $7.5B | $12.8B | ||
| Q2 24 | $7.2B | $12.2B | ||
| Q1 24 | $8.0B | $11.9B |
| Q4 25 | 16.40× | 11.49× | ||
| Q3 25 | 14.96× | 9.74× | ||
| Q2 25 | 17.99× | 12.14× | ||
| Q1 25 | 7.18× | 16.52× | ||
| Q4 24 | 7.11× | 18.81× | ||
| Q3 24 | 6.20× | 17.75× | ||
| Q2 24 | 5.53× | 60.11× | ||
| Q1 24 | 5.27× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $137.0M | $141.0M |
| Free Cash FlowOCF − Capex | $92.0M | $96.0M |
| FCF MarginFCF / Revenue | 6.9% | 6.4% |
| Capex IntensityCapex / Revenue | 3.4% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $51.0M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $137.0M | $141.0M | ||
| Q3 25 | $146.0M | $264.0M | ||
| Q2 25 | $93.0M | $220.0M | ||
| Q1 25 | $-112.0M | $75.0M | ||
| Q4 24 | $138.0M | $390.0M | ||
| Q3 24 | $139.0M | $141.0M | ||
| Q2 24 | $-620.0M | $332.0M | ||
| Q1 24 | $-290.0M | $76.0M |
| Q4 25 | $92.0M | $96.0M | ||
| Q3 25 | $105.0M | $218.0M | ||
| Q2 25 | $50.0M | $181.0M | ||
| Q1 25 | $-196.0M | $43.0M | ||
| Q4 24 | $29.0M | $335.0M | ||
| Q3 24 | $63.0M | $99.0M | ||
| Q2 24 | $-693.0M | $300.0M | ||
| Q1 24 | $-392.0M | $30.0M |
| Q4 25 | 6.9% | 6.4% | ||
| Q3 25 | 7.0% | 13.6% | ||
| Q2 25 | 3.1% | 11.4% | ||
| Q1 25 | -14.3% | 2.8% | ||
| Q4 24 | 2.1% | 21.0% | ||
| Q3 24 | 4.2% | 6.3% | ||
| Q2 24 | -44.6% | 18.7% | ||
| Q1 24 | -28.8% | 1.8% |
| Q4 25 | 3.4% | 3.0% | ||
| Q3 25 | 2.7% | 2.9% | ||
| Q2 25 | 2.7% | 2.4% | ||
| Q1 25 | 6.1% | 2.1% | ||
| Q4 24 | 8.0% | 3.5% | ||
| Q3 24 | 5.0% | 2.7% | ||
| Q2 24 | 4.7% | 2.0% | ||
| Q1 24 | 7.5% | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | 3.17× | 1.65× | ||
| Q2 25 | — | 1.52× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | -10.33× | 1.70× | ||
| Q1 24 | -5.37× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CC
| Titanium Technologies | $563.0M | 42% |
| Thermal And Specialized Solutions | $443.0M | 33% |
| Advanced Performance Materials | $312.0M | 23% |
| Other Non-Reportable Segment | $12.0M | 1% |
OGN
Segment breakdown not available.
